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To the Editor:
Familial adenomatous polyposis (FAP) is an autosomal
dominantly inherited disorder that results when adenoma-
tous polyposis coli (APC) protein function is lost due to a
mutation in the APC gene on chromosome 5q21. The
development of colorectal cancer stands out as the most
prevalent complication, with an incidence of almost 100%
by the age of 35–40 years if left untreated. Moreover,
extraintestinal complications for which medical attention is
essential are not rare, and estimated life time risk presumably
exceeds 30%. Affected individuals can develop thyroid and
pancreatic cancer, hepatoblastomas, central nervous system
tumors (especially medulloblastomas), and various benign
tumors like adrenal adenomas, osteomas, desmoid tumors,
and dental abnormalities. We report a case of Cushing’s
syndrome due to multiple adrenal adenomas as an extra-
intestinal manifestation of FAP.
A 32-year-old man was referred to the Department of
Endocrinology because of ankle edema, facial plethora and
spontaneous hematomas. He gained 15 kg during the last
4 years. His medical history was remarkable for a subtotal
colectomy with ileorectal anastomosis at age 16, as primary
prophylactic treatment for FAP. Five years later, he under-
went a proctectomy with an ileal pouch-anal anastomosis.
Regular endoscopic follow-up according to current guide-
lines was performed. On physical examination, there were
clear features of hypercortisolism such as a moon face,
buffalo hump, enlarged fat pads that fill the supraclavicular
fossae, easy bruisability of the skin, huge purple striae at
the enlarged lower abdomen, proximal muscle wasting, and
hypertension. Endocrine analyses revealed an increased
urinary cortisol excretion (4,300 mmol/24 h, reference
<270), while plasma adrenocorticotropic hormone concen-
trations were suppressed, pointing to an adrenal cause of
Cushing’s syndrome. Subsequently, computed tomography
revealed two tumors (3.5×3.5 and 3.2×3.0 cm) of the left
adrenal gland with benign radiological characteristics.
Adrenal masses are frequently occurring extraintestinal
manifestations of FAP. They are two to four times more
common in FAP than in the general population, but the
clinical spectrum of these masses in FAP does not seem to be
different. This can range from benign clinically silent adeno-
mas to classical Cushing’s or Conn’s syndrome. Adrenocor-
tical carcinomas and pheochromocytomas have also been
described. Once a mass in the adrenals is identified, hormonal
and (serial) radiological evaluation according the NIH
conference guidelines needs to be performed. Patients should
be referred to an endocrinologist. This is especially important
since recent reports suggest that up to 20% of patients with an
incidentally found adrenal mass have some form of subtle
hormonal overproduction resulting in an increased risk for
metabolic disorders and cardiovascular disease.
Our patient was cured after left sided adrenalectomy.
Histologic evaluation confirmed the presence of two adeno-
mas, both with monomorphic cellular characteristics. Oste-
oporosis and two impression fractures of thoracic vertebrae
had developed as a consequence of the longstanding hyper-
cortisolemia. Genetic analysis showed a mutation of the APC
gene at codon 1353 (c.4057delG, p.Glu1353fsX62), pre-
dicted to result in a premature stop codon.
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